ClinicalTrials.Veeva

Menu

Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)

S

St George's, University of London

Status

Enrolling

Conditions

Urinary Tract Infections (UTIs)

Study type

Observational

Funder types

Other

Identifiers

NCT07012421
2024.0149
226461/Z/22/Z (Other Grant/Funding Number)

Details and patient eligibility

About

  1. General objective

    This pilot study aims to compare the prevalence of resistance in bacteria causing UTIs among patients seeking care outside the hospital settings (CDROs) to the WHO-GLASS data.

  2. Specific objectives

2-1 Primary objectives:

  • Determine the resistance profiles of uropathogens and carriage strains from patients with uncomplicated UTIs attending community drug retail outlets (CDRO's) and in hospitals*.
  • Compare the resistance profiles of the uropathogens from patients with uncomplicated UTIs attending CDROs and hospitals to those in the WHO-GLASS database.
  • Explore the patient pathway and its impact on antibiotic use among patients presenting to CDROs and hospitals with uncomplicated UTIs.
  • Determine the appropriateness of antimicrobial use in the treatment of uncomplicated UTIs among patients presenting to CDROs and hospitals

2-2 Secondary objectives:

  • Compare resistance profiles among the uropathogens from patients from two neighbourhoods in Kampala.
  • Examine environmental samples between the study sites to determine the presence of antibiotic residues and AMR two neighbourhoods in Kampala.

Enrollment

3,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must have one or more of the following clinical presentations regardless of age:

acute (< 2 weeks) dysuria. increased urinary urgency and frequency, irritation, discharge. increased lower abdominal pain or discomfort and sometimes gross haematuria.

  • In elderly patients with pre-existing urinary symptoms: increased acute urinary changes.

Exclusion criteria

  • People without symptoms of UTI.

Trial design

3,000 participants in 2 patient groups

Namuwongo community
Description:
The Namuwongo informal settlement is located in the urban area of Kampala, Uganda. An estimated 70% of residents in the informal settlement routinely (within the last month) use antibiotics. Houses are overcrowded with residents paying to use public toilets. The investigators are recruiting from community drug retail outlets and the outpatient department of Kitsugu health centre located next to Namuwongo.
Muyenga community
Description:
The Muyenga and Bukasa neighbourhoods are also located in the urban area of Kampala, Uganda, but is more affluent than the Namuwongo informal settlement. Residents in Muyenga can afford more expensive treatments at community drug retail outlets (CDROs)/clinics. The investigators are recruiting from community drug retail outlets and the outpatient department of Naguru hospital located next to Muyenga and Bukasa neighbourhoods.

Trial contacts and locations

1

Loading...

Central trial contact

Catrin E Moore, DPhil, MBA, MSc, BSc, FRSB, FI; Henry Kajumbula, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems